Osprey Medical, Inc.'s (ASX:OSP) Path To Profitability
Dec 28
OSP Share Price Performance
AU$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
OSP Community Narratives
There are no narratives available yet.
Osprey Medical, Inc. Key Details
Last Reported Earnings
Dec 31, 2021
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.39
- Gross Margin
- 35.98%
- Net Profit Margin
- -512.51%
- Debt/Equity Ratio
- 0%
Osprey Medical, Inc. Competitors
Snowflake Analysis
About OSP
- Founded
- 2005
- Employees
- n/a
- CEO
- WebsiteView website
Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.
Market Insight
Why today’s lofty prices test investors, and how to stay invested without losing your edge.
Continue reading
U.S. Market Performance
- 7 Days: 0.5%
- 3 Months: 8.2%
- 1 Year: 20.8%
- Year to Date: 10.6%
Over the last 7 days, the market has remained flat, although notably the Communication Services sector gained 4.7% in that time. More promisingly, the market is up 21% over the past year. Earnings are forecast to grow by 15% annually. Market details ›